Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma.

Cabiati, Manuela; Gaggini, Melania; DE Simone, Paolo; Basta, Giuseppina; Gastaldelli, Amalia; Del Ry, Silvia

Cabiati, Manuela; Gaggini, Melania; DE Simone, Paolo; Basta, Giuseppina; Gastaldelli, Amalia; Del Ry, Silvia.

Afiliación

Cabiati M; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
Gaggini M; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
DE Simone P; Department of Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy.
Basta G; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
Gastaldelli A; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy.
Del Ry S; Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy - delry@ifc.cnr.it.

Minerva Endocrinol (Torino) ; 46(3): 367-369, 2021 09.

Article en En | MEDLINE | ID: mdl-32623844

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Osteoprotegerina; Ligando RANK; Receptor Activador del Factor Nuclear kappa-B; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Ligando RANK / Receptor Activador del Factor Nuclear kappa-B / Osteoprotegerina / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Minerva Endocrinol (Torino) Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google